|
|
 |
OMIDRIA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
OCTYLDODECANOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
OMEGAVEN Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
NURTEC ODT Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
OLEYL ALCOHOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
OSENI Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
NOURIANZ Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|